Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$453.50
▼ $14.92 (-3.2%)
Market data updated: 09/17 08:34 PM
Fundamentals updated: 09/17/2026
News analyzed: 09/17/2026
Market Cap
$36.84B
Day Range
$450.22 - $473.27
52-Week Range
$339.01 - $792.16
Beta
—
Next Earnings
02.11.2026
AXON is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
-39.7% (1Y)
Strengths: 5/31 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Revenue growth (last year)
Revenue growth (last year): 33.5%
Growth
Biggest negative driver
DCF Fair Value
Estimated fair value: $15.86 vs. price $453.50 (-96.5%)
Fair Value
What to watch next
When today echoes the past.
80/100
Similarity
15
Historical Matches
90/100
Analog Quality
+4.4%
Median 40D Outcome
48/100
Pattern Consistency
🟢 Bullish
67%
+6.8% … +19.3%
🟡 Base
13%
-0.7% … -0.7%
🔴 Bearish
20%
-6.7% … -2.5%
Typical timeframe (based on real historical rates clearing a 60% bar): 5 trading days.
📌 Bottom line: Out of 15 similar historical cases for this stock, 67% (95% CI 42%–85%) saw the stock rise within 20 trading days, with a median gain of +6.7%.
Echo #1 — Momentum Breakout
5 occurrence(s) · 80% historical success
Echo #2 — Oversold Reversal
4 occurrence(s) · 50% historical success
Historical outcome rate is not a probability — it's what happened in this specific historical sample, with a 95% confidence range.
| Horizon | Positive rate (95% CI) | Median | 25th–75th pct | Baseline median |
|---|---|---|---|---|
| 5D | 67% (42%–85%) | +2.7% | -0.8% … +5.8% | +0.6% |
| 10D | 80% (55%–93%) | +8.7% | +2.1% … +12.5% | +1.4% |
| 20D | 67% (42%–85%) | +6.7% | -0.7% … +17.5% | +2.7% |
| 40D | 60% (36%–80%) | +4.4% | -1.6% … +23.1% | +4.6% |
| 60D | 67% (42%–85%) | +22.1% | -0.7% … +41.7% | +9.6% |
Sample size: 15 analogs, each at least 10 trading days apart (no double-counted overlapping events).
What happened after each historical match (20-day return)
| Date | Similarity | Regime | 20D outcome | 60D outcome |
|---|---|---|---|---|
| 2026-04-08 | 80/100 | ✓ High Volatility | -1.4% | +59.0% |
| 2018-11-29 | 72/100 | ✓ High Volatility | -0.7% | +22.1% |
| 2026-02-10 | 72/100 | ✓ High Volatility | +15.8% | -4.5% |
| 2025-02-28 | 71/100 | ✓ High Volatility | +1.2% | +41.2% |
| 2021-05-18 | 71/100 | Consolidation | +23.1% | +51.1% |
| 2021-03-10 | 69/100 | High Volatility | +6.7% | +0.0% |
| 2018-11-14 | 67/100 | High Volatility | -9.9% | +8.3% |
| 2021-12-16 | 67/100 | Downtrend | -3.5% | -14.7% |
| 2025-11-13 | 66/100 | Downtrend | +1.3% | -22.0% |
| 2021-03-29 | 65/100 | High Volatility | +16.6% | +23.6% |
| 2022-05-06 | 64/100 | High Volatility | +7.0% | +21.5% |
| 2026-05-13 | 62/100 | Downtrend | +18.4% | +58.3% |
| 2022-06-21 | 62/100 | High Volatility | +22.5% | +42.3% |
| 2018-08-13 | 62/100 | Consolidation | +19.6% | -1.5% |
| 2026-04-23 | 60/100 | High Volatility | -0.7% | +30.2% |
Every accepted match is compared to today across 6 domains (price structure, momentum, technical, volatility, volume, relative strength) using z-scored feature distances — no single indicator dominates. Matches within 10 trading days of each other count as one event, not independent evidence. Outcome rates use a Wilson confidence interval (never a raw percentage alone), the mean return is winsorized against extreme outliers, and "Analog Quality" separately captures sample size, data completeness, and regime match — distinct from raw similarity. Relative strength is measured against SPY and against XLI (this stock's sector).
Cross-stock analogs — real other companies, not this stock's own history.
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
41
Today
58
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
26d ago · $627.75
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
26d ago · $627.75
Evidence: 10 bullish / 2 bearish technical signals agreeing
What happened after
29d ago · $645.72
Evidence: +3.4pp vs. sector average today
What happened after
29d ago · $645.72
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
29d ago · $645.72
Evidence: 10 bullish / 2 bearish technical signals agreeing
What happened after
30d ago · $621.18
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
30d ago · $621.18
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🕰️ StockIQ Time Machine
What did StockIQ know — and when? Pick a date from the real accumulated history.
As of August 18, 2026
Then
58
$619.64
Now
41
$453.50
What happened since
Signals detected by this date
No signals detected by this date
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
40
Quality
42
Value
33
Momentum
19
Risk
48
Sentiment
100
Fundamental
45
Institutional
0
Stocks with a similar DNA right now
SCANNING AXON...
Recent media coverage of Axon Enterprise has centered on its stock performance and financial momentum, particularly highlighting a **3% rise since its last earnings report**, driven by strong growth in its **Connected Devices unit**, which saw a **34.6% revenue surge** from products like the TASER 10 and counter-drone equipment. Additionally, there was attention on an **insider sale** by the company’s president, who offloaded **$9.6 million in stock** under a pre-planned trading program, though he retained a significant stake. Analysts and investors are now assessing whether this growth can continue.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Axon Enterprise. News trend score: 100. Reason: 13 of the last 20 articles are positive, versus 4 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
43
🎯 Conviction (vs. Emotion)
36
Psychology
47
Fundamentals
45
Technical
19
Valuation
33
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The price rise has far outpaced the actual improvement in fundamental data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price (3M)
+7%
Market Narrative
65
Fundamental Reality
36
Narrative Gap
+29
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market’s dominant herding behavior reflects AXON’s underperformance relative to peers, with traders aligning despite weak momentum (-16.8% ROC) and modest volume. Overconfidence persists due to extreme valuation (+3087% above DCF), while euphoria is muted by negative momentum. The key question is whether the narrative gap (55 vs. 36) will widen further, as traders may anchor to outdated optimism. Low confirmation bias (0) suggests no reinforcing signals, leaving herding vulnerable to peer shifts or volatility spikes.
Updated: 09/09/2026, 01:44 AM
What could change this?
👥 What the crowd believes
"Axon (AXON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues."
"AXON's Connected Devices revenues surge 34.6%, fueled by TASER 10, counter-drone equipment and strong international bookings."
"Argus Adjusts Price Target on Axon Enterprise to $600 From $460, Keeps Buy Rating"
📈 11D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 94/100
🔴 Weakest match
Thorstein Veblen — 12/100
🗣️ Why do they disagree?
The stark contrast in verdicts for AXON reflects deep methodological divides between investors prioritizing cyclical positioning, liquidity, and trend-following versus those demanding strict valuation discipline or defensive qualities. Samuel Armstrong Nelson’s near-perfect score highlights AXON’s favorable cycle position, suggesting it’s oversold and ripe for a rebound, while Walter Bagehot’s strong liquidity score implies resilience in downturns—both aligning with macro or credit-focused strategies. In contrast, Benjamin Graham’s lowest score and Morgan Housel’s warning about volatility underscore AXON’s failure to meet traditional value or patient-holding criteria, as its lack of defensive metrics and perceived speculative growth (per Veblen) clash with deep-value or behavioral frameworks. Meanwhile, Peter Lynch and Philip Fisher’s rejection stem from AXON not meeting their growth-at-a-reasonable-price or quality thresholds, while Jesse Livermore’s negative trend verdict aligns with his strict adherence to trading with the market’s momentum—even if others see relative strength. The middle-ground methodologies (Marks, Smith, Loeb) suggest AXON is a cautious pick at best, balancing moderate risk with cyclical or market-cycle considerations, while the lowest scorers (Veblen, Housel) flag it as emotionally driven or volatile, illustrating how AXON’s profile splits investors between opportunistic traders and those seeking stability or long-term fundamentals.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 94
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟢 82
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 79
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 65
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 56
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 55
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 47
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟡 42
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 42
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 41
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 33
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 31
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 26
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 23
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 20
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 12
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Based on the last 300 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 10 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
59.7%
Operating Margin
-2.2%
Net Margin
4.5%
EBITDA Margin
0.8%
ROE
3.8%
ROA
1.8%
ROIC
—
EPS
$1.60
Cash
$1.20B
Total Debt
$1.81B
Current Ratio
2.53
Debt/Equity
0.56
How is Fair Value calculated? →
Current Price
$453.50
Estimated Fair Value (DCF)
$15.86
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-96.5%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
25.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 25.0% | $93.85M | $86.10M |
| 2 | 19.4% | $112.03M | $94.30M |
| 3 | 13.8% | $127.44M | $98.41M |
| 4 | 8.1% | $137.79M | $97.62M |
| 5 | 2.5% | $141.24M | $91.80M |
Base FCF (last actual year)
$75.08M
Terminal Value
$2.23B
Present Value of Terminal Value
$1.45B
Enterprise Value
$1.92B
Net Debt
$609.58M
Equity Value
$1.31B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$39.37
Tangible Book Value per Share (Tangible NAV)
$20.34
Sentiment based on basic keywords (not AI) — 13 positive, 3 neutral, 4 negative out of the last 20 articles.
ChartMill · 17.9.2026
ChartMill · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 16.9.2026
ChartMill · 16.9.2026
ChartMill · 16.9.2026
ChartMill · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Benzinga · 16.9.2026
SeekingAlpha · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Axon Enterprise (AXON) currently has a StockIQ AI score of 41/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AXON currently scores 41/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, AXON's estimated fair value is $15.86, which is 96.5% below the current price of $453.50. This is one valuation model among several signals in the fair-value category, not a price target.
AXON's technical score is 19/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Revenue growth (last year): 33.5%; Current ratio: 2.53; +4.3% over the last 3 months relative to the index.
Based on the real signals StockIQ computed: Estimated fair value: $15.86 vs. price $453.50 (-96.5%); Operating margin: -2.2% (negative); Operating margin is eroding over time.
StockIQ has no recorded dividend payment history for AXON.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 24 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 1,033 | -1,033 | $512.70 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 1,251 | -1,251 | $511.43 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 197 | -197 | $513.38 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 1,774 | -1,774 | $508.45 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 410 | -410 | $503.74 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 1,104 | -1,104 | $505.59 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 71 | -71 | $501.99 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 744 | -744 | $506.48 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 1,319 | -1,319 | $509.32 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 749 | -749 | $507.48 |
| SMITH PATRICK W | Open Market Sale | 8.9.2026 | 1,348 | -1,348 | $510.59 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 91 | -91 | $592.51 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 40 | -40 | $595.17 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 1,663 | -1,663 | $579.76 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 280 | -280 | $586.43 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 793 | -793 | $580.59 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 109 | -109 | $590.21 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 280 | -280 | $588.46 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 661 | -661 | $565.37 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 120 | -120 | $582.84 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 318 | -318 | $581.76 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 477 | -477 | $584.54 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 565 | -565 | $585.72 |
| Isner Joshua | Open Market Sale | 31.8.2026 | 898 | -898 | $569.70 |
| Fields Isaiah | Tax Withholding in Shares | 31.8.2026 | 763.159 | -763.159 | $566.56 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
3,617,068 shares short as of 2026-08-31 · vs. 3,563,990 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
62.2% of trading volume this week was short selling, vs. 53.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology